|

Dr. Jaya Sivaswami Tyagi , M.Sc.,Ph.D
Professor ,Biotechnology
Education / Professional Studies:
I.S.C., Loreto Convent,
Lucknow, 1969 (First class); B.Sc. from
University of
Delhi, 1973; M.Sc. from
University of
Delhi, 1975; Ph.D. from
University of
Delhi, 1979.
Membership of Professional Bodies:
Society of
Biological Chemists (India), Guha Research Conference, National Academy of
Sciences (Allahabad), Microbiological Society of India, Indian Society for
Cell Biology, American Society of Microbiology.
TEACHING/ RESEARCH EXPERIENCE
|
|
|
Institution |
Responsibilities
|
Post Held |
From |
To |
|
V.P.Chest Institute,
Delhi
|
Research |
JRF, SRF
|
Oct. 1975
|
July 1979 |
|
National Cancer Institute, NIH,
Bethesda,
MD,
USA
|
Research |
International Visiting Fellow and
International Visiting Associate in Dr. Ira Pastan’s laboratory |
Aug. 1979 |
June 1983 |
|
CSIR Centre for
Biochemical Technology,
Delhi |
Research, production of enzymes and
reagents for scientific community, teaching |
Scientist C |
June 1983
|
May 1987 |
|
AIIMS
New Delhi
|
Teaching and research |
Associate Professor
Additional Professor
Professor
|
June 1987
July 1990
July 2001 |
June 1991
June 2001
Present
|
Awards, fellowships and membership of professional bodies.
· National
Science Talent Fellow from 1970 to 1979 of the Indian Council of
Agricultural Research. Scholarship during B.Sc, M.Sc. and fellowship during
Ph.D.
· First
position in the University of Delhi in B.Sc. (1973).
·
Recipient of
University Gold Medal for securing first position in M.Sc (1975).
· First
position in Biochemistry in the Agriculture Research Service (ARS)
examination held in February 1978 by the ICAR.
·
Recipient
of Dr. Kona Sampath Kumar Memorial Prize, University of Delhi, 1985.
· Short-term
Overseas Biotechnology Associateship by the Department of Biotechnology,
Ministry of Science & Technology during April-July 1991.
· Member,
American Society for Microbiology, 1995 onwards
· Elected
Member of Guha Research Conference in 1996.
· Elected
Fellow of the National Academy of Sciences, India in 1999.
· Recipient
of P.S. Sarma Memorial Award of the Society of Biological Chemists (India),
1999.
· Recipient
of New Millennium Science Medal, Indian Science Congress 2000.
· Recipient
of National Women Bioscientist Award, 1999 awarded by the Department of
Biotechnology, Govt. of India, 2000.
· Life
member of Society of Biological Chemists (India), Indian Society of Cell
Biology, Association of Microbiologists of India, Amercian Society for
Microbiology, Guha Research Conference, National Academy of Sciences.
Key Activities.
Ø
Teaching
: Teaching Masters in Biotechnology students and post MD/MS trainees.
Supervision of M. Biotechnology, Ph.D. students, training of post-MD and
WHO-sponsored candidates, summer training of students from other
Biotechnology teaching programmes in India.
Ø
Research:
Broad area:
Mycobacterium tuberculosis and tuberculosis.
Specific
areas:
Ø
Molecular
basis of virulence, gene regulation and expression.
Ø
Development,
validation and commercialization of TB diagnostic technologies.
Ø
Membership of
Editorial boards of indexed international journals/Review Committees of
National bodies and Institutions.
Ø Member
of
i) DBT expert group for Tuberculosis ii) ICMR Project Review Committee for
Tuberculosis and Leprosy iii) Screening Committee for DBT National and ICGEB
Postdoctoral iv) CSIR Selection Committee for appointment of SRF and RA v)
Member, AIIMS Patent cell vi) Member, AIIMS Institutional Biosafety
Committee for Recombinant DNA molecules
Current research efforts.
My research
group focuses on tuberculosis in
the following areas:
-
understanding the role
of key dormancy regulating system, DevR-DevS/Rv2027c
(Rv3133c-Rv3132c/Rv2027c), in pathogenesis with special reference to
dormancy and adaptation within macrophages
-
developing efficient diagnostic tools for pulmonary and extra pulmonary
tuberculosis. The USP multipurpose diagnostic technology has been
developed which encompasses sample processing, highly sensitive smear
microscopy, culture on solid/liquid medium and PCR. This technology is
being licensed.
-
exploiting the
DevR-DevS two-component system as a novel antitubercular target.
-
study the
transcriptional control of DevR-DevS two-component system
-
decipher the
environmental signals which DevS and Rv2027c sensor kinases respond to
in vitro and macrophages.
-
evaluate the binding
properties of DevR to DNA of its regulatory target genes.
7.
to test candidate compounds for
antimycobacterial activity
8.
develop efficient and rapid
diagnostic tools to diagnose extra pulmonary
tuberculosis based on nucleic
acid and /or antibody/antigen detection
Most of the
work has been published in peer-reviewed journals or has been filed for
patents or are in press/ preparation.
Future plans.
-
understand the role of
DevR in pathogenesis in the Mitchison guinea pig model of virulence
using wild-type and mutant strains of M. tuberculosis.
Recoverable viable bacteria, histology and gene expression (of host and
M. tuberculosis genes) will be assessed.
2.
to test candidate compounds for
antimycobacterial activity.
Recent Publications (2002-2007).
1. Haldar
S, Chakravorty S, Bhalla M, De Majumdar S. & Tyagi JS (2007) Simplified
detection of Mycobacterium tuberculosis in sputum using smear microscopy and
PCR with molecular beacons. J Med Microbiol. 56:1356-1362
2. Pathak
D, Chakravorty S, Hanif M & Tyagi JS (2007) Lysis of tubercle bacilli in
fresh and stored sputum specimens: implications for diagnosing tuberculosis
in stored and paucibacillary specimens by PCR. BMC Microbiology 2007, 7:83
doi:10.1186/1471-2180-7-83
3. Taneja
NK & Tyagi JS (2007) Resazurin reduction assays for screening of
anti-tubercular compounds against dormant and actively growing Mycobacterium
tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis. J
Antimicrob Chemotherapy 60:288–293.
4. Sharma
D & Tyagi JS (2007) The value of comparative genomics in understanding
mycobacterial virulence: Mycobacterium tuberculosis H37Ra genome sequencing
– a worthwhile endeavour. J. Biosci. 32:185-189.
5. Sharma
D, Bose A, Shakila H, Das TK, Tyagi JS & Ramanathan VD (2006) Expression of
mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and
Acr, within lung granulomas throughout guinea pig infection. FEMS Immunol
Med Microbiol 48:329-336.
6. Tyagi
JS (2006) The timeless legacy of Robert Koch. Resonance 11:20-28
7. Chakravorty
S, Pathak D, Dudeja M, Haldar S & Tyagi JS (2006) PCR amplification of
shorter fragments from the devR (Rv3133c) gene significantly increases the
sensitivity of tuberculosis diagnosis. FEMS Micro. Lett. 257: 306-311.
8. Bagchi
G, Chauhan S, Sharma D & Tyagi JS (2005) Transcription and autoregulation of
the Rv3134c-devR-devS operon of Mycobacterium tuberculosis. Microbiology
151:4045-4053.
9. Sen
MK, Chakravorty S & Tyagi JS (2005) Polymerase chain reaction to identify
Mycobacterium tuberculosis in patients with tuberculous lymphadenopathy.
Natl. Medical J. India. 18:302-303.
10. Chakravorty
S, Sen MK & Tyagi JS (2005) Diagnosis of extrapulmonary tuberculosis by
smear, culture and PCR using Universal Sample Processing technology. J. Clin.
Microbiol. 43:4357-4362.
11. Haldar
S, De Majumdar S, Chakravorty S, Tyagi JS, Bhalla & Sen MK. (2005) Detection
of acid-fast bacilli in postlysis debris of clinical specimens
improves the reliability
of PCR. J. Clin. Microbiol. 43: 3580-3581.
12. Chakravorty
S & Tyagi JS (2005) Novel Multipurpose Methodology for Detection of
Mycobacteria in Pulmonary and Extrapulmonary Specimens by Smear Microscopy,
Culture, and PCR. J. Clin. Microbiol. 43: 2697-2702.
13. Chakravorty
S, Dudeja M, Hanif M & Tyagi JS. (2005) Utility of Universal Sample
Processing Methodology, Combining Smear Microscopy, Culture, and PCR, for
Diagnosis of Pulmonary Tuberculosis. J. Clin. Microbiol. 43: 2703-2708
14. Saini
DK & Tyagi JS. (2005) High-throughput microplate phosphorylation assaysbased
on DevR-DevS/Rv2027c 2-component signal transduction pathway to screen for
novel antitubercular compounds. J. Biomol. Screening. 10:215-224.
15. Tyagi
JS. (2004) T.A. Venkitasubramanian. Current Science, 87:1303
16. Prabhakar,
S, Mishra A, Singhal A, Katoch VM, Thakral SS, Tyagi JS & Prasad HK (2004)
Use of the hupB gene encoding a histone-like protein of Mycobacterium
tuberculosis as a target for detection and differentation of M. tuberculosis
and M. bovis. J. Clin. Microbiol. 42:2724-2732.
17. Saini,
DK, Malhotra V & Tyagi JS. (2004) Cross talk between DevS sensor kinase
homologue, Rv2027c, and DevR response regulator of Mycobacterium
tuberculosis. FEBS Lett., 565:75-80.
18. Saini
DK, Malhotra V, Dey D, Pant N, Das TK & Tyagi JS. (2004) DevR-DevS is a
bonafide two-component system of Mycobacterium tuberculosis that is
hypoxia-responsive in the absence of the DNA-binding domain of DevR.
Microbiology, 150:865-875.
19. Malhotra
V, Sharma D, Ramanathan VD, Shakila H, Saini DK, Chakravorty S, Das TK, Li
Q, Silver RF, Narayanan PR & Tyagi JS. (2004) Disruption of response
regulator gene, devR, leads to attenuation in virulence of Mycobacterium
tuberculosis. FEMS Microbiol. Lett., 231:237-245.
20. Bajpai
M, Pratap A, Somitesh C, Tyagi J. (FEB 2004) Angiotensin converting enzyme
gene polymorphism in Asian Indian children with congenital uropathies. J
Urol. 171:838-40.
21. Tyagi
JS & Sharma D. (2004) Signal transduction systems of mycobacteria with
special reference to M. tuberculosis. Current Science, 86:93-102.
22. Tyagi
JS & Saini DK (2004) Did the loss of two-component systems initiate
pseudogene accumulation in M. leprae? Microbiology, 150: 4-7.
23. Tyagi
JS, Chakravorty S & Dudeja M (2003) Diagnosis of Tuberculosis: Conventional
and new approaches. Trends Clin Biochem Lab Medicine, pp 325-329.
24. Bagchi
G, Mayuri & Tyagi JS (2003) Hypoxia-responsive expression of Mycobacterium
tuberculosis Rv3134c and devR promoters in Mycobacterium smegmatis.
Microbiology 149: 2303-5.
25. Tyagi JS &
Sharma D. (2002) Genomic study of Mycobacterium tuberculosis and its
clinical applications. Ind. J. Pediatr. 69:S29-S38.
26. Saini, D.K.,
Pant, N., Das, T.K. & Tyagi, J.S. Cloning, overexpression, purification and
matrix – assisted refolding of DevS (Rv 3132c) Histidine Protein Kinase of
Mycobacterium tuberculosis. Protein Exp. Purification (2002) 25:203-208.
27. Mayuri, Bagchi, G. Das, T.K. & Tyagi, J.S. Molecular analysis
of the dormancy response in Mycobacterium smegmatis: Expression analysis of
genes encoding DevR-DevS two-component system, Rv3134c and chaperone
a-crystallin homologues.
FEMS Microbiol. Lett. (2002) 211:231-237.
28. Tyagi, J.S. & Sharma, D. M. smegmatis and tuberculosis. Trends
Microbiol. (2002) 10:68-69.
Patents.
Indian:
5 International: 3
Indian:
-
A rapid, efficient,
single - tube extraction procedure for the isolation of PCR –
amplifiable M.tuberculosis DNA from clinical specimens, Appl. No.
497/ DEL/ 2000.
-
A process for
identifying and producing DevR protein of Mycobacterium tuberculosis
has been granted, 1999.
-
A process for
identifying a novel target for the development of therapeutic modalities
and drugs effective against tuberculosis, Appl. No. 1286/ DEL/ 2001.
-
A simple and fast
process for evaluating promoter activity of persistent M.
tuberculosis in hypoxic conditions using M. smegmatis as a
surrogate host. Appl. No. 981/DEL/2003.
-
A method for diagnosis
of tuberculosis by smear microscopy, culture and polymerase chain
reaction using processed clinical samples and kit thereof has been
granted, 2003.
International:
-
A process for
identifying a novel target for the development of therapeutic modalities
and drugs effective against tuberculosis, Appl. No. PCT/IN02/00022, in
national phase in several countries.
-
A screening method for
developing drugs against pathogenic microbes having two-component
system. US patent Appl. No. 60/418,837 and PCT Appl. No. PCT/IB03/04555.
-
A method for diagnosis
of tuberculosis by smear microscopy, culture and polymerase chain
reaction using processed clinical samples and kit thereof. PCT Appl. No.
PCT/IB 03/03211.
|